- In February 2021, Fresenius Kabi has expanded its facilities in Austria, strengthening its production capabilities and innovation in pharmaceuticals and medical technologies. This expansion enhances manufacturing efficiency, ensures a steady supply of critical care products, and supports research advancements. By increasing capacity and operational excellence, the company reinforces its market presence and meets the growing Middle East and Africa demand for healthcare solutions
- In February 2024, Viatris and Idorsia have entered a major Middle East and Africa research and development collaboration to advance innovative therapies across multiple therapeutic areas. This partnership leverages Idorsia’s drug discovery expertise and Viatris’ Middle East and Africa reach, accelerating the development of groundbreaking treatments and expanding both companies’ pipelines, reinforcing their commitment to addressing unmet medical needs worldwide
